← Leaderboards
Patrick L. Purdon
Massachusetts General Hospital
$20,862,691
Attributed
$35,240,145
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,240,145 · 13
By mechanism
R01$19,073,677 · 5
R42$10,664,672 · 4
DP2$2,654,750 · 1
R44$1,499,986 · 1
K25$885,060 · 1
R21$462,000 · 1
Top collaborators
- Tuan Le Mau14 shared
- Bradford C Dickerson13 shared
- Michael J Prerau8 shared
- Emery Neal Brown4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Zhongcong Xie$19,705,169
- Emery Neal Brown$29,784,538
- Shiqian Shen$9,623,224
- Jason P Stockmann$7,037,700
- Julian M Goldman$9,298,716
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMonitorBrainGeneral AnesthesiaAnestheticsPharmaceutical PreparationsElectroencephalographyOperative Surgical ProceduresAnesthesia ProceduresNeurophysiologySedation ProcedureResponseBaseCaringS DiseasePhysiologicalCognitiveDoseUnconscious StateSignal ProcessingAlgorithmsPostoperative PeriodBiological MarkersSource Localization
Grant awards (43)
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,637,641
R01 · FY2025 · AG · contact PI
Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias$1,499,986
R44 · FY2025 · AG
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care$1,255,373
R42 · FY2025 · NS
Advanced signal processing methods for neural data analysis to support development of brain dynamic biomarkers for research and clinical applications in patients with Alzheimer's and related dementias$1,226,486
R01 · FY2025 · AG · contact PI
Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patientsâ¯$998,162
R42 · FY2025 · AG
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans$601,503
R01 · FY2025 · DA · contact PI
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,686,029
R01 · FY2024 · AG · contact PI
Advanced signal processing methods for neural data analysis to support development of brain dynamic biomarkers for research and clinical applications in patients with Alzheimer's and related dementias$1,263,216
R01 · FY2024 · AG · contact PI
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care$1,208,662
R42 · FY2024 · NS
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements$987,966
R42 · FY2024 · DA
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans$612,534
R01 · FY2024 · DA · contact PI
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia to minimize postoperative opioid requirements$221,325
R42 · FY2024 · DA
Characterizing sleep brain dynamics associated with Alzheimer's disease pathology and progression in humans using EEG source localization and PET$1,871,738
R01 · FY2023 · AG · contact PI
Advanced signal processing methods for neural data analysis to support development of brain dynamic biomarkers for research and clinical applications in patients with Alzheimer's and related dementias$1,303,780
R01 · FY2023 · AG · contact PI
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements$981,839
R42 · FY2023 · DA
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans$571,682
R01 · FY2023 · DA · contact PI
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care$474,416
R42 · FY2023 · NS
Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patientsâ¯$299,893
R42 · FY2023 · AG
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans$150,740
R01 · FY2023 · DA · contact PI
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients$1,214,935
R42 · FY2022 · AG
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements$994,837
R42 · FY2022 · DA
Characterizing brain dynamic biomarkers of fentanyl using intracranial and high-density electroencephalogram in humans$743,289
R01 · FY2022 · DA · contact PI
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients$1,227,656
R42 · FY2021 · AG
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$811,850
R01 · FY2021 · AG · contact PI
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$631,035
R01 · FY2021 · AG · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$826,867
R01 · FY2020 · AG · contact PI
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$639,246
R01 · FY2020 · AG · contact PI
Personalized anesthetic brain monitoring: Developing novel systems, sensors, and algorithms for aging, dementia, and Alzheimers disease patients$449,671
R42 · FY2020 · AG
Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements$349,937
R42 · FY2020 · DA
A pilot study to characterize brain dynamic biomarkers of fentanyl for opioid overdose monitoring$210,000
R21 · FY2020 · DA · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$837,363
R01 · FY2019 · AG · contact PI
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$646,062
R01 · FY2019 · AG · contact PI
A pilot study to characterize brain dynamic biomarkers of fentanyl for opioid overdose monitoring$252,000
R21 · FY2019 · DA · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$844,721
R01 · FY2018 · AG · contact PI
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$653,243
R01 · FY2018 · AG · contact PI
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG$854,981
R01 · FY2017 · AG · contact PI
The Aging Brain Under General Anesthesia: Neurophysiology, Neuroimaging Biomarkers of Aging and Alzheimer's Disease, and Post-Operative Cognitive Outcomes$659,671
R01 · FY2017 · AG · contact PI
Multimodal Functional Imaging of Auditory Perception Under General Anesthesia$177,012
K25 · FY2011 · NS · contact PI
Multimodal Functional Imaging of Auditory Perception Under General Anesthesia$177,012
K25 · FY2010 · NS · contact PI
A Neural Systems Approach to Monitoring and Drug-Delivery for General Anesthesia$2,654,750
DP2 · FY2009 · OD · contact PI
Multimodal Functional Imaging of Auditory Perception Under General Anesthesia$177,012
K25 · FY2009 · NS · contact PI
Multimodal Functional Imaging of Auditory Perception Under General Anesthesia$177,012
K25 · FY2008 · NS · contact PI
Multimodal Functional Imaging of Auditory Perception Under General Anesthesia$177,012
K25 · FY2007 · NS · contact PI